BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Endocrine gland cancer

1. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. TSHR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. NCOA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. PALB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. FOXL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. KCNJ5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. TMEM127
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. BRIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. SDHAF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. CACNA1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. ATP1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. EPAS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. ATP2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. RNF43
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. MECOM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. PMS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. FANCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. MSN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. PICALM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. CDK12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. MAP2K2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. GNAQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. RAD51B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. AKAP9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. CANT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [